As a crypto-analyst who once tracked failing biotech firms, I watched Eyenovia’s radical pivot—from near bankruptcy to HYPE-backed DeFi leader. This isn’t hype. It’s a calculated move: burning transaction fees to shrink supply, locking value into a self-sustaining chain. I’ve seen this play before—in microcap equities—but never with this level of structural discipline. HYPE isn’t just a token; it’s an asset engine.